These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 17319920)
1. Pharmacokinetics and drug interactions with zonisamide. Sills G; Brodie M Epilepsia; 2007 Mar; 48(3):435-41. PubMed ID: 17319920 [TBL] [Abstract][Full Text] [Related]
2. Zonisamide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy. Peters DH; Sorkin EM Drugs; 1993 May; 45(5):760-87. PubMed ID: 7686468 [TBL] [Abstract][Full Text] [Related]
3. Zonisamide: pharmacokinetics, efficacy, and adverse events in children with epilepsy. Wallander KM; Ohman I; Dahlin M Neuropediatrics; 2014 Dec; 45(6):362-70. PubMed ID: 25133701 [TBL] [Abstract][Full Text] [Related]
4. Lack of a clinically significant effect of zonisamide on phenytoin steady-state pharmacokinetics in patients with epilepsy. Levy RH; Ragueneau-Majlessi I; Garnett WR; Schmerler M; Rosenfeld W; Shah J; Pan WJ J Clin Pharmacol; 2004 Nov; 44(11):1230-4. PubMed ID: 15496640 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of adjunctive zonisamide therapy for refractory partial seizures. Baulac M; Leppik IE Epilepsy Res; 2007 Jul; 75(2-3):75-83. PubMed ID: 17553670 [TBL] [Abstract][Full Text] [Related]
6. Lack of pharmacokinetic interactions between steady-state zonisamide and valproic acid in patients with epilepsy. Ragueneau-Majlessi I; Levy RH; Brodie M; Smith D; Shah J; Grundy JS Clin Pharmacokinet; 2005; 44(5):517-23. PubMed ID: 15871637 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed? Johannessen SI; Tomson T Clin Pharmacokinet; 2006; 45(11):1061-75. PubMed ID: 17048972 [TBL] [Abstract][Full Text] [Related]
8. Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs. Patsalos PN; Perucca E Lancet Neurol; 2003 Jun; 2(6):347-56. PubMed ID: 12849151 [TBL] [Abstract][Full Text] [Related]
9. Zonisamide: review of its use in epilepsy therapy. Zareba G Drugs Today (Barc); 2005 Sep; 41(9):589-97. PubMed ID: 16341290 [TBL] [Abstract][Full Text] [Related]
12. Clinically relevant drug interactions with antiepileptic drugs. Perucca E Br J Clin Pharmacol; 2006 Mar; 61(3):246-55. PubMed ID: 16487217 [TBL] [Abstract][Full Text] [Related]
13. Carbamazepine pharmacokinetics are not affected by zonisamide: in vitro mechanistic study and in vivo clinical study in epileptic patients. Ragueneau-Majlessi I; Levy RH; Bergen D; Garnett W; Rosenfeld W; Mather G; Shah J; Grundy JS Epilepsy Res; 2004 Nov; 62(1):1-11. PubMed ID: 15519127 [TBL] [Abstract][Full Text] [Related]
14. Interactions between zonisamide and conventional antiepileptic drugs in the mouse maximal electroshock test model. Borowicz KK; Luszczki JJ; Sobieszek G; Ratnaraj N; Patsalos PN; Czuczwar SJ Eur Neuropsychopharmacol; 2007 Mar; 17(4):265-72. PubMed ID: 16876388 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic interactions of topiramate. Bialer M; Doose DR; Murthy B; Curtin C; Wang SS; Twyman RE; Schwabe S Clin Pharmacokinet; 2004; 43(12):763-80. PubMed ID: 15355124 [TBL] [Abstract][Full Text] [Related]
17. Introduction to zonisamide. Baulac M Epilepsy Res; 2006 Feb; 68 Suppl 2():S3-9. PubMed ID: 16413170 [TBL] [Abstract][Full Text] [Related]
18. The ideal pharmacokinetic properties of an antiepileptic drug: how close does levetiracetam come? Perucca E; Johannessen SI Epileptic Disord; 2003 May; 5 Suppl 1():S17-26. PubMed ID: 12915337 [TBL] [Abstract][Full Text] [Related]
20. Newer therapies in the drug treatment of epilepsy. McAuley JW; Biederman TS; Smith JC; Moore JL Ann Pharmacother; 2002 Jan; 36(1):119-29. PubMed ID: 11816240 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]